User contributions for Mohammad Nikoohemmat
A user with 10 edits. Account created on 21 December 2023.
22 February 2024
- 16:4516:45, 22 February 2024 diff hist +30 N Sandbox:MNH Created page with "=====bold kardan subtitle=====" current
- 16:4316:43, 22 February 2024 diff hist +712 Eplontersen No edit summary current
- 13:5313:53, 22 February 2024 diff hist −132 Eplontersen No edit summary Tag: Visual edit
- 13:4913:49, 22 February 2024 diff hist +359 Eplontersen No edit summary
- 13:4013:40, 22 February 2024 diff hist −13 Eplontersen No edit summary
- 13:3613:36, 22 February 2024 diff hist +156 Eplontersen No edit summary
- 13:3413:34, 22 February 2024 diff hist −14,537 Eplontersen Blanked the page Tags: Blanking Visual edit
- 13:3113:31, 22 February 2024 diff hist +93 N Birch triterpenes Created page with "{{DrugProjectFormSinglePage |authorTag=Mohammad Nikoohemmat |genericName=birch triterpenes }}"
- 13:2413:24, 22 February 2024 diff hist +14,537 N Eplontersen Created page with "{{DrugProjectFormSinglePage |authorTag=Mohammad Nikoohemmat |genericName=Eplontersen |aOrAn=a |drugClass=transthyretin-directed antisense oligonucleotide |indicationType=treatment |indication=WAINUA is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |adverseReactions=Most common adverse reactions (that occurred in at least 9% of patients treated with WAINUA) were vitamin A decreased and vomiting. |fdaLIADAdult..."
- 12:3312:33, 22 February 2024 diff hist +92 N Template:MNH Created page with "Mohammad Nikoohemmat, M.D.[mailto:mohammadnikoo1375@gmail.com]" current